A study co-authored by MCB and Chemistry Professor, and HHMI Investigator, Jennifer Doudna details a safer and more effective method of delivering CRISPR-Cas9 gene-editing technology.
CRISPR-Gold has potential use in the future for powerful gene therapy for genetic diseases, such as Duchenne muscular dystrophy.
CRISPR in action: A model of the Cas9 protein cutting a double-stranded piece of DNA.